Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.
<h4>Background</h4>Atypical antipsychotic medications are widely prescribed for the adjunctive treatment of depression, yet their total risk-benefit profile is not well understood. We thus conducted a systematic review of the efficacy and safety profiles of atypical antipsychotic medicat...
Saved in:
Main Authors: | Glen I Spielmans, Margit I Berman, Eftihia Linardatos, Nicholas Z Rosenlicht, Angela Perry, Alexander C Tsai |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/7ffe1f0191a34caca1e30bed0cee47d9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical antipsychotics as add-on treatment in late-life depression
by: Cakir S, et al.
Published: (2016) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
by: Luan SX, et al.
Published: (2018) -
Atypical depression: current perspectives
by: Łojko D, et al.
Published: (2017) -
Atypical antipsychotics in the treatment of early-onset schizophrenia
by: Hrdlicka M, et al.
Published: (2015) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
by: Gabriel A
Published: (2013)